News
Lilly said it’s moving ‘with urgency toward global regulatory submissions to potentially meet the needs of patients who are ...
Novo Nordisk said on Monday it is offering its diabetes drug Ozempic for $499 per month to eligible cash-paying type 2 ...
Prescription savings platform GoodRx is collaborating with pharma giant Novo Nordisk to make Ozempic and Wegovy pens ...
Indian pharma companies are challenging Novo Nordisk's semaglutide patents in court, which could pave the way for cheaper ...
With around 73 percent of Americans enjoying their daily coffee fix, it’s natural to wonder how your morning cup might ...
As the patent for semaglutide nears its end, Novo Nordisk's dominance in the weight-loss market is being challenged. The ...
Hims & Hers investors hit with more bad news as Novo Nordisk partners with GoodRx to offer discounted access to competing products. ETFs with high concentration in HIMS may face risks and losses.
An embattled Iowa telepharmacy owner, fined $25,000 for selling fake Ozempic, says he didn't know the weight-loss drug was counterfeit ...
Dentists claim weight-loss drugs could majorly impact users' saliva glands, helping gum disease to fester in their mouths.
3hon MSN
Eli Lilly’s once-daily weight loss pill succeeds in latest trial, paving the way for global approval
Eli Lilly said its once-daily weight loss pill was effective for people with obesity and type 2 diabetes in a key trial, ...
23h
E! News on MSNMeghan Trainor Reacts to Fans Saying They Didn’t “Recognize” Her Amid Transformation
Meghan Trainor reacted after fans said she looked unrecognizable in a recent video of herself doing the Nicki Minaj stiletto challenge with a new sleek long blonde ponytail and bangs.
Eli Lilly and Novo Nordisk already produce popular GLP-1s in the Triangle. A Swiss drugmaker says its future Wake County site ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results